EUVIMEDEUVIMED entdecken
Editorial

Skeletal Muscle Mass Loss and Glucagon-Like Peptide-1 Receptor Agonists: Are Older Patients at Risk?

Anjali P Kakkar, Eric Ravussin, Thierry H Le Jemtel iD

Annals of Internal Medicine · 2025-07 · 178 (7) · 1031-1032

DOI: 10.7326/annals-24-03950 ↗

Kurz gefasst

Editorial in der Zeitschrift Annals of Internal Medicine, 2025-07. Verfasst von Anjali P Kakkar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiology, John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana (A.P.K., T.H.L.J.). Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Section of Cardiology, John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana (A.P.K., T.H.L.J.).
  • Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana (E.R.).

ORCID-Profile: Thierry H Le Jemtel

Zitieren

APA

Kakkar, A. P., Ravussin, E., & Le Jemtel, T. H. (2025). Skeletal Muscle Mass Loss and Glucagon-Like Peptide-1 Receptor Agonists: Are Older Patients at Risk?. Annals of Internal Medicine, 178(7), 1031-1032. https://doi.org/10.7326/annals-24-03950

Vancouver

Kakkar AP, Ravussin E, Le Jemtel TH. Skeletal Muscle Mass Loss and Glucagon-Like Peptide-1 Receptor Agonists: Are Older Patients at Risk?. Annals of Internal Medicine. 2025;178(7):1031-1032. doi:10.7326/annals-24-03950

BibTeX
@article{Kakkar2025,
  author = {Kakkar, Anjali P and Ravussin, Eric and Le Jemtel, Thierry H},
  title = {Skeletal Muscle Mass Loss and Glucagon-Like Peptide-1 Receptor Agonists: Are Older Patients at Risk?},
  journal = {Annals of Internal Medicine},
  year = {2025},
  volume = {178},
  number = {7},
  pages = {1031--1032},
  doi = {10.7326/annals-24-03950}
}
Kostenlos starten →